COMMONWEALTH EQUITY SERVICES, LLC

Position in LKFT — Lakefront Biotherapeutics NV

CIK 312272 WALTHAM, MA

Position in LKFT

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$343,300

+$28,330 QoQ

Shares Held

11,451

+9.1% QoQ

Ownership

0.017%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#34

of 78 holders

Holding Since

Jun 2023

10 quarters on record

Healthcare · as of Jun 30, 2026

COMMONWEALTH EQUITY SERVICES, LLC holds $124,479,036 across 113 Biotechnology names. LKFT ranks #52 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	50,813	$25,240,341
2	TGTX	Tg Therapeutics, Inc.	186,987	$10,273,065
3	REGN	Regeneron Pharmaceuticals, Inc.	14,671	$9,147,955
4	EXEL	Exelixis, Inc.	105,998	$5,767,351
5	TARS	Tarsus Pharmaceuticals, Inc.	79,888	$5,028,150
6	MRNA	Moderna, Inc.	66,546	$4,660,216
7	KRYS	Krystal Biotech, Inc.	12,116	$4,503,153
8	ARWR	Arrowhead Pharmaceuticals, Inc.	55,170	$4,496,906

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$343,300	11,451	+9.1%	Shares	Sole	2026-07-29
2026-03-31	$314,970	10,499	+18.5%	Shares	Sole	2026-04-27
2025-12-31	$289,754	8,861	+0.1%	Shares	Sole	2026-02-12
2025-09-30	$306,494	8,848	+5.6%	Shares	Sole	2025-10-22
2025-06-30	$234,612	8,382	-26.2%	Shares	Sole	2025-08-06
2025-03-31	$285,363	11,360	+74.8%	Shares	Sole	2025-05-09
2024-03-31	$209,300	6,500	0.0%	Shares	Sole	2024-04-29
2023-12-31	$264,225	6,500	+8.3%	Shares	Sole	2024-02-06
2023-09-30	$207,300	6,000	+9.1%	Shares	Sole	2023-10-23
2023-06-30	$223,630	5,500	—	Shares	Sole	2023-08-10
No filing history on record for this holder in this stock.